Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A

PURPOSE: To assess the impact of botulinum toxin type A (BTX-A) on signs and symptoms of dry eye (DE) in affected eye of hemifacial spasm (HFS) patients and to compare the prevalence of DE between affected and non-affected eye in HFS patients. PATIENTS AND METHODS: This prospective study included pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Jariyakosol, Supharat, Uthaithammarat, Lita, Chatwichaikul, Nattakarn, Kasetsuwan, Ngamjit, Chongpison, Yuda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090983/
https://www.ncbi.nlm.nih.gov/pubmed/33953536
http://dx.doi.org/10.2147/OPTH.S305817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090983/
https://www.ncbi.nlm.nih.gov/pubmed/33953536
http://dx.doi.org/10.2147/OPTH.S305817

Ejemplares similares